Skip to main content
Livermore
Livermore
ZHEN

Intercept Pharmaceuticals, Inc.

ICPTDelisted Nov 8, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001270073

Intercept Pharmaceuticals, Inc. was delisted on Nov 8, 2023; its insiders filed their last Form 4 on Nov 13, 2023; 146 institutions reported holding it in 13F filings for Q3 2023, worth $724.6M in total; no superinvestor held it.

Superinvestors holding ICPT, Q3 2023

See all superinvestors

No superinvestor reported holding ICPT in Q3 2023.

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of ICPT each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q4 2021

    0 superinvestors holding at quarter end

    Sold out
    Maverick Capital

  2. Q3 2021

    1 superinvestor holding at quarter end

    Reduced
    Maverick Capital (−94.2%)

  3. Q2 2021

    1 superinvestor holding at quarter end

    Added
    Maverick Capital (+32.8%)